LIMK2 and neoplasm: In this study, we report that LIMK2 acts as a survival factor in neuroblastoma cell lines to counteract the effect of diverse chemotherapeutic drugs and shed light on the signaling pathways that may associate LIMK2 with tumor cell resistance.